Merck KGaA's 2015 Sales Jump on Life Sciences Contribution, Sigma-Aldrich Acquisition | GenomeWeb

NEW YORK (GenomeWeb) – Germany's Merck KGaA reported today that its revenues for fiscal year 2015 climbed 13 percent year over year, driven by growth in its life science segment and including the contribution of Sigma-Aldrich.

Sales for the life science segment jumped 25 percent year over year to €3.36 billion ($3.71 billion) from €2.68 billion. Within that segment, the company's process solutions business had sales of €1.43 billion, while sales for its lab solutions business were around €1.20 billion, and revenues for the bioscience business area were €450 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.